Скачать с ютуб The Best Multiple Sclerosis Medication! в хорошем качестве

The Best Multiple Sclerosis Medication!

2:11 Rebif vs. Avonex 3:17 Betaseron vs. Avonex 3:54 Rebif 44mcg vs. Rebif 22cmg 4:30 Copaxone vs. Avonex 6:05 Copaxone vs Betaseron & Copaxone vs. Rebif 6:41 Gilenya vs. Avonex 8:23 Zeposia (ozanimod) vs. Avonex 9:00 Tecfidera Vs. Copaxone 10:22 Aubagio vs. Rebif 11:18 Imuran Vs. Avonex 12:16 Imuran vs. IFN 12:55 Tysabri vs. Avonex 14:53 Rebif + steroids 16:04 Laquinimod vs. Avonex 16:53 HSCT vs. Novantrone 19:01 HSCT vs. other DMTs 21:06 Lemtrada vs. Rebif 22:24 methotrexate vs. Avonex 23:16 Ocrevus vs. Rebif 24:28 Mavenclad (cladribine) vs. IFN 25:25 Ofatumumab vs. Aubagio 27:43 FINAL RANKING Comment or ask questions below! I would be happy to answer! Subscribe on YouTube for more videos every Wednesday! Make video requests in the comments section! My book "Resilience in the Face of Multiple Sclerosis" on Amazon: https://www.amazon.com/dp/B07WP7H5LK Sources: HSCT review: https://www.ncbi.nlm.nih.gov/pmc/arti... ASCLEPIOS: https://onlinelibrary.ectrims-congres... Barry Singer’s post:   / 1172489071903379461   OPERA: https://www.nejm.org/doi/full/10.1056... Placebo controlled cladribine study (Clarity): https://www.nejm.org/doi/full/10.1056... The ONWARD (Oral Cladribine Added ON To Interferon beta-1a in Patients With Active Relapsing Disease): [phase II] https://nn.neurology.org/content/5/5/... Lemtrada vs. Rebif: (product label of Lemtrada, page 7) http://products.sanofi.us/Lemtrada/Le... Ozanimod vs. avonex: https://www.ncbi.nlm.nih.gov/pubmed/2... https://www.ncbi.nlm.nih.gov/pubmed/3... • 1) An examination of the results of the EVIDENCE, INCOMIN, and phase III studies of interferon beta products in the treatment of multiple sclerosis ; Timothy Vartanian, MD, PhD; Clinical Therapeutics Volume 25, Issue 1, January 2003, Pages 105–118 • 2) Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis; M. Etemadifar,; Prof. M. Janghorbani,; V. Shaygannejad ; Journal of Neurology ; December 2007, Volume 254, Issue 12, pp 1723-1728 • 3) Non-Inferiority of Azathioprine Versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis Patients: A Multicentric Randomized Trial (Main Trial). Abstract P460 • 4) Drug Class Review: Disease-modifying Drugs for Multiple Sclerosis; Final Update 1 Report • Drug Class Reviews; Beth Smith, DO, Susan Carson, MPH, Rochelle Fu, PhD, Marian McDonagh, PharmD, Tracy Dana, MLS, Benjamin KS Chan, MS, Sujata Thakurta, MPA-HA, and Andrew Gibler, PharmD.; Portland (OR): Oregon Health & Science University; August 2010. • 5) Editorial found here: http://www.msforum.net/Site/ViewPDF/V... • 6) J Neurol. 2014 Feb 18. [Epub ahead of print] A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis. Vollmer TL1, http://www.ncbi.nlm.nih.gov/pubmed/24... Dr. Brandon Beaber is a board-certified neurologist with subspecialty training in multiple sclerosis and other immunological diseases of the nervous system. He is a partner in the Southern California Permanente Medical Group and practices in Downey, California (South Los Angeles). He has several publications on MS epidemiology and has participated in clinical trials for MS therapeutics. You can follow him on twitter @Brandon_Beaber where he regularly posts about MS news and research. Follow me on twitter:   / brandon_beaber   Music: INNER GRACE - Copyright 2018 Wilton Vought Source: Really Really Free Music Link:    • Видео   T he video material by Dr. Brandon Beaber is general educational material on health conditions and is not intended to be used by viewers to diagnose or treat any individual's medical condition. Specifically, this material is not a substitute for individualized diagnostic and treatment advice by a qualified medical/health practitioner, licensed in your jurisdiction, who has access to the relevant information available from diagnostic testing, medical interviews, and a physical examination. To the extent that Dr. Beaber endorses any lifestyle change, behavioral intervention, or supplements, the viewer should consult with a qualified healthcare professional to determine the safety and efficacy of the intervention in light of their individualized information.